Combination of dual serum fluorescence, AFP and hepatic function tests is valuable to identify HCC in AFP-elevated liver diseases

Wang, T; Zhang, KH; Hu, PP; Wan, QS; Han, FL; Zhou, JM; Huang, DQ; Lv, NH

Zhang, KH (reprint author), Nanchang Univ, Jiangxi Inst Gastroenterol & Hepatol, Dept Gastroenterol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.

ONCOTARGET, 2017; 8 (58): 97758

Abstract

Serum alpha-fetoprotein (AFP) levels elevated in benign liver diseases (BLD) represent a challenge in hepatocellular carcinoma (HCC) diagnosis. The pr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索